The Specific Aims of the Inhalation Core are to provide housing of mice prior to inhalation experiments in a pathogen-free environment and controlled exposures to asbestos and ovalbumin (OVA). The objective of the Transgenic Mouse Core is to provide transgenic mice to the members of the Program Project. The generation, maintenance and screening of new and previously generated conventional transgenic mice will be centralized in this Core. In addition, this Core aims to develop a new experimental approach that involves stable integration of bacterial artificial chromosomes (BACs) in the mouse genome.
The Specific Aims of this Core are: i. To provide a Core service for the generation of new transgenic mice (F2 C3H x C57Bl/6) expressing specific transgenes in pulmonary epithelial cells. The new transgenic mice that are proposed in this Program Project will be generated in the University of Vermont Transgenic Mouse Core, directed by Dr. Rincon. ii. To centralize the backcross process required to obtain each of the new and previously generated transgenic mice in two specific strain backgrounds. The new F2 C3H x C57Bl/6 transgenic mice will be backcrossed for seven generations with wild type inbred mice (C57Bl/6 and Balb/c) to obtain homogeneous genetic background. iii. To screen transgenic mice by molecular analyses of genomic DNA (PCR, slot blot) and provide the necessary number of mice to the investigators of the Program. The screening process will also be centralized to prevent variability and increase efficiency and reproducibility of the results from different projects. iv. To develop new applications involving the use of transgenic mice to study lung fibrosis. An alternative approach to complement the classical transgenic mouse models will be developed during the Program funding period: the generation of transgenic mice by BACs.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Vermont & St Agric College
United States
Zip Code
Sayan, Mutlay; Mossman, Brooke T (2016) The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol 13:51
Sabo-Attwood, Tara; Ramos-Nino, Maria E; Eugenia-Ariza, Maria et al. (2011) Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis. Am J Pathol 178:1975-85
Buder-Hoffmann, Sylke A; Shukla, Arti; Barrett, Trisha F et al. (2009) A protein kinase Cdelta-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestos. Am J Pathol 174:449-59
Levis, Jamie; Loi, Roberto; Butnor, Kelly J et al. (2008) Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am J Respir Cell Mol Biol 38:16-25
Dostert, Catherine; Petrilli, Virginie; Van Bruggen, Robin et al. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674-7
Janssen-Heininger, Yvonne M W; Mossman, Brooke T; Heintz, Nicholas H et al. (2008) Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 45:1-17
Manning, Christopher B; Sabo-Attwood, Tara; Robledo, Raymond F et al. (2008) Targeting the MEK1 cascade in lung epithelium inhibits proliferation and fibrogenesis by asbestos. Am J Respir Cell Mol Biol 38:618-26
Barlow, Christy A; Kitiphongspattana, Kajorn; Siddiqui, Nazli et al. (2008) Protein kinase A-mediated CREB phosphorylation is an oxidant-induced survival pathway in alveolar type II cells. Apoptosis 13:681-92
Fukagawa, Naomi K; Li, Muyao; Sabo-Attwood, Tara et al. (2008) Inhaled asbestos exacerbates atherosclerosis in apolipoprotein E-deficient mice via CD4+ T cells. Environ Health Perspect 116:1218-25
Mossman, Brooke T (2008) Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays. Regul Toxicol Pharmacol 52:S200-3

Showing the most recent 10 out of 58 publications